# OnCo record paper-howlader-us-incidence-breast-subtypes-jnci-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-howlader-us-incidence-breast-subtypes-jnci-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-howlader-us-incidence-breast-subtypes-jnci-2014" ;
  schema:name "US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status"@en ;
  schema:description "The first US national count of breast cancer by receptor subtype, from 2010 when cancer registries began recording HER2: 12.2 percent of cases were triple-negative, and Black women had the highest rate of that subtype."@en ;
  schema:url <https://onco.cc/key-papers/paper-howlader-us-incidence-breast-subtypes-jnci-2014/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1093/jnci/dju055>, <https://pubmed.ncbi.nlm.nih.gov/24777111/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1093/jnci/dju055> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Howlader N, Altekruse SF, Li CI, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:institutions <https://onco.cc/institutions/nci/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-diversity/> ;
  onco:journals <https://onco.cc/journals/jnci/> .
